Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Abeona Therapeutics Inc (NASDAQ: ABEO) was $6.12 for the day, down -4.67% from the previous closing price of $6.42. In other words, the price has decreased by -$4.67 from its previous closing price. On the day, 1.55 million shares were traded.
Ratios:
Our analysis of ABEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 05, 2025, initiated with a Outperform rating and assigned the stock a target price of $16.
On July 03, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
On May 30, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $21.Stifel initiated its Buy rating on May 30, 2024, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 27 ’25 when Alvino Mark sold 2,000 shares for $6.38 per share. The transaction valued at 12,760 led to the insider holds 90,435 shares of the business.
Alvino Mark bought 2,000 shares of ABEO for $12,762 on May 27 ’25. On May 16 ’25, another insider, Alvino Mark, who serves as the Director of the company, sold 8,000 shares for $5.68 each. As a result, the insider received 45,440 and left with 92,435 shares of the company.
Stock Price History:
Over the past 52 weeks, ABEO has reached a high of $7.32, while it has fallen to a 52-week low of $3.93. The 50-Day Moving Average of the stock is 14.33%, while the 200-Day Moving Average is calculated to be 7.94%.
Shares Statistics:
A total of 48.95M shares are outstanding, with a floating share count of 45.21M. Insiders hold about 11.62% of the company’s shares, while institutions hold 59.05% stake in the company.
Earnings Estimates
Currently, 3.0 analysts are dedicated to thoroughly evaluating and rating the performance of Abeona Therapeutics Inc (ABEO) in the stock market.The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.27 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.96 and -$1.2 for the fiscal current year, implying an average EPS of -$1.06. EPS for the following year is -$0.16, with 3.0 analysts recommending between $0.04 and -$0.27.
Revenue Estimates
For the next quarter, 7 analysts are estimating revenue of $6.61M. There is a high estimate of $10.87M for the next quarter, whereas the lowest estimate is $2.33M.
Based on 6 analysts’ estimates, the company’s revenue will be $107.35M in the next fiscal year. The high estimate is $130.35M and the low estimate is $64.75M.
